Table 1.
General characteristics of pregnant women surveyed (n = 700)
| Characteristic | Number of respondents | Proportion (%) |
|---|---|---|
| Parity (number of previous pregnancies ≥28 weeks) | ||
| First pregnancy | 148 | 21.1 |
| Second pregnancy | 173 | 24.7 |
| Third or more pregnancies | 379 | 54.2 |
| Number of ANC visits in last pregnancy (n = 552)* | ||
| None | 32 | 5.8 |
| One or two visits | 90 | 16.3 |
| Three visits | 161 | 29.2 |
| Four or more visits | 269 | 48.7 |
| Education level completed | ||
| None or never completed primary | 113 | 16.1 |
| Primary education | 252 | 36.0 |
| Ordinary level education | 179 | 25.6 |
| Advanced level education | 87 | 12.4 |
| Tertiary education | 69 | 9.9 |
| Knowledge on SP-IPTp use during pregnancy | ||
| Prevent malaria in mother (or unborn baby) | 399 | 57.0 |
| Treatment of malaria | 109 | 15.4 |
| Do not know | 187 | 26.7 |
| Other response | 6 | 0.9 |
| Experienced SP-IPTp unwanted effects (n = 629)** | ||
| None | 432 | 68.7 |
| Mild (headache/dizziness, nausea/vomiting, fever) | 105 | 16.7 |
| Severe (skin reaction, abdominal pain, general weakness) | 92 | 14.6 |
*Data excludes primigravidae, **data from only previous users of SP-IPTp.